收藏切换
Research Progress of in vitro Activity Evaluation Methods for Antibody Drug Conjugates
收藏切换
Ying CHEN1, 2, 3, Can WANG2, 3, Hong SHAO2, 3, *, Weidong XU2, *
Chinese Journal of Pharmaceuticals | 2025, 56(6) : 723 - 729
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2025, 56(6): 723-729
• Perspectives & Review •
Research Progress of in vitro Activity Evaluation Methods for Antibody Drug Conjugates
Full
Ying CHEN1, 2, 3, Can WANG2, 3, Hong SHAO2, 3, *, Weidong XU2, *
Affiliations
  • 1.School of Pharmaceutical Sciences, Fudan University, Shanghai 201203
  • 2.NMPA Key Lab. for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai Institute for Food and Drug Control, Shanghai 201203
  • 3.Shanghai Quality Inspection and Testing Center for Innovative Biological Products, Shanghai 201203
Published: 2025-06-10 doi: 10.16522/j.cnki.cjph.2025.06.003
Outline
收藏切换

Antibody drug conjugates (ADCs) are biotherapeutic agents composed of a monoclonal antibody covalently linked to a cytotoxic payload via a chemical linker. Their unique structure combines the dual advantages of antibody-mediated targeted delivery and the potent cytotoxicity, demonstrating remarkable clinical efficacy in solid tumors, hematological malignancies and other therapeutic areas. ADCs are expected to play a pivotal role in future global drug development. Throughout the entire lifecycle of ADC development, manufacturing, and quality control, their binding affinity and biological activity critically influence therapeutic efficacy and safety. Comprehensive characterization of in vitro biological activity not only serves as the cornerstone for ensuring the clinical performance but also drives the resolution of current technical challenges and the advancement of innovative drug development. This review systematically discusses the current in vitro biological activity evaluation methods of ADCs, focusing on five functional modules based on the mechanism of ADCs: target binding activity, internalization efficiency, payload cytotoxicity, bystander effect, and Fc-mediated functions, aiming to provide methodological references for ADC development and quality control.

antibody drug conjugate  /  in vitro biological activity  /  binding activity  /  quality control  /  safety  /  research progress
陈颖, 王灿, 邵泓, 徐伟东. 抗体偶联药物体外活性评价方法研究进展. 中国医药工业杂志, 2025 , 56 (6) : 723 -729 . DOI: 10.16522/j.cnki.cjph.2025.06.003
Ying CHEN, Can WANG, Hong SHAO, Weidong XU. Research Progress of in vitro Activity Evaluation Methods for Antibody Drug Conjugates[J]. Chinese Journal of Pharmaceuticals, 2025 , 56 (6) : 723 -729 . DOI: 10.16522/j.cnki.cjph.2025.06.003
Year 2025 volume 56 Issue 6
32
9
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2025.06.003
  • Receive Date:2024-09-03
  • Online Date:2026-11-18
  • Published:2025-06-10
Article Data
Affiliations
History
  • Received:2024-09-03
Funding
Affiliations
    1.School of Pharmaceutical Sciences, Fudan University, Shanghai 201203
    2.NMPA Key Lab. for Quality Control of Therapeutic Monoclonal Antibodies, Shanghai Institute for Food and Drug Control, Shanghai 201203
    3.Shanghai Quality Inspection and Testing Center for Innovative Biological Products, Shanghai 201203
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2025.06.003
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT